Manufacturers and industry officials attending the American Institute of Ultrasound Medicine’s 44th annual convention in April in San Francisco will get a chance to examine the emerging role of Doppler sonography in liver and kidney evaluation.
Manufacturers and industry officials attending the American Institute of Ultrasound Medicines 44th annual convention in April in San Francisco will get a chance to examine the emerging role of Doppler sonography in liver and kidney evaluation.
Color-flow Doppler has grown increasingly popular for gynecological applications, and physicians are beginning to adopt this form of ultrasound for the examination of stroke and head trauma patients (SCAN Ultrasound Market Report 2/00).
Attendees will get a better understanding of renal artery and vein scans, as well as those of the hepatic portal, hepatic venous system, and hepatic artery.
About 2500 people and 1000 manufacturers are expected to attend the AIUM convention April 1-5 at the Moscone Convention Center and San Francisco Marriott Hotel.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.